Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001711459-22-000001
Filing Date
2022-07-06
Accepted
2022-07-06 12:28:59
Documents
1
Effectiveness Date
2022-07-06
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 8467
  Complete submission text file 0001711459-22-000001.txt   9491
Mailing Address 953 INDIANA STREET SAN FRANCISCO CA 94107
Business Address 953 INDIANA STREET SAN FRANCISCO CA 94107 (415) 742-1283
Prellis Biologics, Inc (Filer) CIK: 0001711459 (see all company filings)

EIN.: 815455517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-451265 | Film No.: 221067992